FDA — authorised 13 November 2001
- Application: NDA021278
- Marketing authorisation holder: SANDOZ
- Local brand name: FOCALIN
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 ADHD Medication in United States
FDA authorised ADHD Medication on 13 November 2001
Marketing authorisation
Other Psychiatry/Neurology approved in United States
Frequently asked questions
Is ADHD Medication approved in United States?
Yes. FDA authorised it on 13 November 2001.
Who is the marketing authorisation holder for ADHD Medication in United States?
SANDOZ holds the US marketing authorisation.